{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:19:57Z","timestamp":1789147197992,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10014-020-00390-y","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T01:03:03Z","timestamp":1609894983000},"page":"81-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8719-9806","authenticated-orcid":false,"given":"Satoshi","family":"Nakasu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Nakasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"390_CR1","unstructured":"Perry A, Louis DN, Budka H, et al. (2016) Meningioma. In Luois DN, et al (ed) WHO classification of tumours of the central nervous system IARC Press, Lyon, pp 231\u2013245"},{"key":"390_CR2","unstructured":"Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepe JJ (2000) Meningiomas. In Kleihues P, Cavenee WK (ed) Pathology and genetics of tumours of the central nervous system IARC Press, Lyon, pp.176\u2013184"},{"key":"390_CR3","unstructured":"Perry A, Louis DN, Scheithauer BW, Budka H, von Demling A (2007) Meningioma. In Luois DN, et al (ed) WHO classification of tumours of the central nervous system IARC Press, Lyon, pp.163\u2013172"},{"key":"390_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF00312803","volume":"208","author":"K Jellinger","year":"1975","unstructured":"Jellinger K, Slowik F (1975) Histological subtypes and prognostic problems in meningiomas. J Neurol 208:279\u2013298","journal-title":"J Neurol"},{"key":"390_CR5","first-page":"11","volume":"29","author":"DK B\u00f6ker","year":"1985","unstructured":"B\u00f6ker DK, Meurer H, Gullotta F (1985) Recurring intracranial meningiomas. Evaluation of some factors predisposing for tumor recurrence. J Neurosurg Sci 29:11\u201317","journal-title":"J Neurosurg Sci"},{"key":"390_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s007010050398","volume":"141","author":"J Ayerbe","year":"1999","unstructured":"Ayerbe J, Lobato DR, De la Cruz J et al (1999) Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis. Acta Neurochir 141:921\u2013932","journal-title":"Acta Neurochir"},{"key":"390_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/BF00697392","volume":"61","author":"D Christensen","year":"1983","unstructured":"Christensen D, Laursen H, Klinken L (1983) Prediction of recurrence in meningiomas after surgical treatment\u2014a quantitative approach. Acta Neuropathol 61:130\u2013134","journal-title":"Acta Neuropathol"},{"key":"390_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2559.1993.tb01218.x","volume":"23","author":"CA McLean","year":"1993","unstructured":"McLean CA, Jolley D, Cukier E, Giles G, Gonzales MF (1993) Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator. Histopathology 23:349\u2013353","journal-title":"Histopathology"},{"key":"390_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1097\/00000478-199712000-00008","volume":"21","author":"A Perry","year":"1997","unstructured":"Perry A, Stafford SL, Scheithauer BW et al (1997) Meningioma grading: an analysis of histology parameters. Am J Surg Pathol 21:1455\u20131465","journal-title":"Am J Surg Pathol"},{"key":"390_CR10","first-page":"2046","volume":"85","author":"A Perry","year":"1999","unstructured":"Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (1999) \u201cMalignancy\u201d in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046\u20132056","journal-title":"Cancer"},{"key":"390_CR11","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/neuonc\/nox071","volume":"19","author":"B Brokinkel","year":"2017","unstructured":"Brokinkel B, Hess K, Mawrin C (2017) Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: a systematic review. Neuro Oncol 19:1298\u20131307","journal-title":"Neuro Oncol"},{"key":"390_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00401-016-1598-1","volume":"132","author":"P Baumgarten","year":"2016","unstructured":"Baumgarten P, Gessler F, Schittenhelm J et al (2016) Brain invasion in otherwise benign meningiomas does not predict tumor recurrence. Acta Neuropathol 132:479\u2013481","journal-title":"Acta Neuropathol"},{"key":"390_CR13","first-page":"248","volume":"78","author":"L Bertero","year":"2019","unstructured":"Bertero L, Dalla Dea G, Osella-Abate S et al (2019) Prognostic characterization of higher-grade Meningiomas: a histopathological score to predict progression and outcome. J Neuropathol Exp Neurol 78:248\u2013256","journal-title":"J Neuropathol Exp Neurol"},{"key":"390_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11060-019-03312-x","volume":"145","author":"A Biczok","year":"2019","unstructured":"Biczok A, Jungk C, Egensperger R et al (2019) Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome. J Neurooncol 145:469\u2013477","journal-title":"J Neurooncol"},{"key":"390_CR15","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/jnen\/nlaa018","volume":"79","author":"A Fioravanzo","year":"2020","unstructured":"Fioravanzo A, Caffo M, Di Bonaventura R et al (2020) A risk score based on 5 clinico-pathological variables predicts recurrence of a typical meningiomas. J Neuropathol Exp Neurol 79:500\u2013507","journal-title":"J Neuropathol Exp Neurol"},{"key":"390_CR16","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00701-019-03956-8","volume":"161","author":"EMS Streckert","year":"2019","unstructured":"Streckert EMS, Hess K, Sporns PB et al (2019) Clinical, radiological, and histopathological predictors for long-term prognosis after surgery for atypical meningiomas. Acta Neurochir (Wien) 161:1647\u20131656","journal-title":"Acta Neurochir (Wien)"},{"key":"390_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.wneu.2016.06.055","volume":"93","author":"DC Spille","year":"2016","unstructured":"Spille DC, Hess K, Sauerland C et al (2016) Brain invasion in meningiomas: incidence and correlations with clinical variables and prognosis. World Neurosurg 93:346\u2013354","journal-title":"World Neurosurg"},{"key":"390_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10143-019-01125-0","volume":"43","author":"M Timme","year":"2020","unstructured":"Timme M, Thomas C, Spille DC et al (2020) Brain invasion in meningiomas: does surgical sampling impact specimen characteristics and histology? Neurosurg Rev 43:793\u2013800","journal-title":"Neurosurg Rev"},{"key":"390_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16","journal-title":"Trials"},{"key":"390_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.5414\/NP300750","volume":"33","author":"J Pizem","year":"2014","unstructured":"Pizem J, Velnar T, Prestor B, Mlakar J, Popovic M (2014) Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen. Clin Neuropathol 33:354\u2013363","journal-title":"Clin Neuropathol"},{"key":"390_CR21","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s00701-019-04073-2","volume":"161","author":"F Wang","year":"2019","unstructured":"Wang F, Xu D, Liu Y et al (2019) Risk factors associated with postoperative recurrence in atypical intracranial meningioma: analysis of 263 cases at a single neurosurgical centre. Acta Neurochir 161:2563\u20132570","journal-title":"Acta Neurochir"},{"key":"390_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"390_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ijrobp.2018.09.019","volume":"103","author":"OC Barrett","year":"2019","unstructured":"Barrett OC, Hackney JR, McDonald AM, Willey CD, Bredel M, Fiveash JB (2019) Pathologic predictors of local recurrence in atypical meningiomas following gross total resection. Int J Radiat Oncol Biol Phys 103:453\u2013459","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"390_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11060-016-2181-2","volume":"129","author":"C Champeaux","year":"2016","unstructured":"Champeaux C, Wilson E, Shieff C, Khan AA, Thorne L (2016) WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment. J Neurooncol 129:337\u2013345","journal-title":"J Neurooncol"},{"key":"390_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.wneu.2016.01.055","volume":"89","author":"C Champeaux","year":"2016","unstructured":"Champeaux C, Dunn L (2016) World Health Organization Grade II meningioma: a 10\u00a0year retrospective study for recurrence and prognostic factor assessment. World Neurosurg 89:180\u2013186","journal-title":"World Neurosurg"},{"key":"390_CR26","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/cncr.10351","volume":"94","author":"DM-T Ho","year":"2002","unstructured":"Ho DM-T, Hsu C-Y, Ting L-T, Chiang H (2002) Histopathology and MIB-1 labeling index predicted recurrence of meningiomas. Cancer 94:1538\u20131547","journal-title":"Cancer"},{"key":"390_CR27","doi-asserted-by":"publisher","first-page":"e804","DOI":"10.1016\/j.wneu.2019.10.002","volume":"133","author":"N Lamba","year":"2020","unstructured":"Lamba N, Hwang WL, Kim DW et al (2020) Atypical histopathological features and the risk of treatment failure in nonmalignant meningiomas: a multi-institutional analysis. World Neurosurg 133:e804\u2013e812","journal-title":"World Neurosurg"},{"key":"390_CR28","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3171\/2016.11.JNS16913","volume":"128","author":"D Kim","year":"2018","unstructured":"Kim D, Niemierko A, Hwang WL et al (2018) Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas. J Neurosurg 128:1123\u20131132","journal-title":"J Neurosurg"},{"key":"390_CR29","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.wneu.2015.04.033","volume":"84","author":"DR Klinger","year":"2015","unstructured":"Klinger DR, Flores BC, Lewis JJ et al (2015) Atypical meningiomas: recurrence, reoperation, and radiotherapy. World Neurosurg 84:839\u2013845","journal-title":"World Neurosurg"},{"key":"390_CR30","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.3171\/2013.9.FOCUS13325","volume":"35","author":"KD Lee","year":"2013","unstructured":"Lee KD, DePowell JJ, Air EL et al (2013) Atypical meningiomas: is postoperative radiotherapy indicated? Neurosurg Focus 35:E15","journal-title":"Neurosurg Focus"},{"key":"390_CR31","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3171\/2017.6.JNS17120","volume":"129","author":"SI Shakir","year":"2018","unstructured":"Shakir SI, Souhami L, Petrecca K et al (2018) Prognostic factors for progression in atypical meningioma. J Neurosurg 129:1240\u20131248","journal-title":"J Neurosurg"},{"key":"390_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1227\/NEU.0000000000000461","volume":"75","author":"SQ Sun","year":"2014","unstructured":"Sun SQ, Kim AH, Cai C et al (2014) Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. Neurosurgery 75:347\u2013355","journal-title":"Neurosurgery"},{"key":"390_CR33","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1227\/NEU.0000000000000462","volume":"75","author":"SQ Sun","year":"2014","unstructured":"Sun SQ, Cai C, Murphy RK et al (2014) Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection. Neurosurgery 75:356\u2013363","journal-title":"Neurosurgery"},{"key":"390_CR34","doi-asserted-by":"publisher","first-page":"35974","DOI":"10.18632\/oncotarget.26313","volume":"9","author":"A Adeli","year":"2018","unstructured":"Adeli A, Hess K, Marwin C et al (2018) Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging. Oncotarget 9:35974\u201335982","journal-title":"Oncotarget"},{"key":"390_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.20892\/j.issn.2095-3941.2017.0024","volume":"14","author":"RA Ahmed","year":"2017","unstructured":"Ahmed RA, Shebl AM, Habashy HO (2017) Expression levels of beta-catenin and galectin-3 in meningioma and their effect on brain invasion and recurrence: a tissue microarray study. Cancer Biol Med 14:319\u2013326","journal-title":"Cancer Biol Med"},{"key":"390_CR36","first-page":"505","volume":"111","author":"EU Akyildiz","year":"2010","unstructured":"Akyildiz EU, Oz B, Comunoglu N, Aki H (2010) The relationship between histomorphological characteristics and Ki-67 proliferation index in meningiomas. Bratisl Lek Listy 111:505\u2013509","journal-title":"Bratisl Lek Listy"},{"key":"390_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00428-006-0285-3","volume":"449","author":"Y-J Kim","year":"2006","unstructured":"Kim Y-J, Ketter R, Henn W et al (2006) Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters. Virchows Arch 449:529\u2013538","journal-title":"Virchows Arch"},{"key":"390_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s10014-018-0318-z","volume":"35","author":"V Barresi","year":"2018","unstructured":"Barresi V, Lionti S, Caliri S, Caffo M (2018) Histopathological features to define atypical meningioma: What does really matter for prognosis? Brain Tumor Pathol 35:168\u2013180","journal-title":"Brain Tumor Pathol"},{"key":"390_CR39","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1007\/s00259-009-1133-x","volume":"36","author":"JW Lee","year":"2009","unstructured":"Lee JW, Kang KW, Park SH et al (2009) 18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma. Eur J Nuclear Med Mol Imaging 36:1574\u20131582","journal-title":"Eur J Nuclear Med Mol Imaging"},{"key":"390_CR40","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1158\/1078-0432.CCR-04-2550","volume":"11","author":"C Marwin","year":"2005","unstructured":"Marwin C, Sasse T, Kirches E et al (2005) Different activation of mitogen-activated protein kinase and AktSignaling is associated with aggressive phenotype of human meningiomas. Clin Cancer Res 11:4074\u20134082","journal-title":"Clin Cancer Res"},{"key":"390_CR41","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.jocn.2007.12.005","volume":"15","author":"A Moradi","year":"2008","unstructured":"Moradi A, Semnani V, Djam H et al (2008) Pathodiagnostic parameters for meningioma grading. J Clin Neurosci 15:1370\u20131375","journal-title":"J Clin Neurosci"},{"key":"390_CR42","first-page":"219","volume":"24","author":"O Ozen","year":"2005","unstructured":"Ozen O, Demirhan B, Altin\u00f6rs N (2005) Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas. Clin Neuropathol 24:219\u2013224","journal-title":"Clin Neuropathol"},{"key":"390_CR43","first-page":"341","volume":"25","author":"J Ruiz","year":"2010","unstructured":"Ruiz J, Martinez A, Hernandez S et al (2010) Clinicopathological variables immunophenotype chromosome 1p36 loss and tumor recurrence of 247meningiomas grade I and II. Histol Histopathol 25:341\u2013349","journal-title":"Histol Histopathol"},{"key":"390_CR44","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/030089160809400316","volume":"94","author":"N Uz\u00fcm","year":"2008","unstructured":"Uz\u00fcm N, Atao\u011flu GA (2008) Histopathological parameters with Ki-67 and bcl-2 in the prognosis of meningiomas according to WHO 2000 classification. Tumori 94:389\u2013397","journal-title":"Tumori"},{"key":"390_CR45","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1136\/jnnp.2007.121582","volume":"79","author":"SY Yang","year":"2008","unstructured":"Yang SY, Park CK, Park SH et al (2008) Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry 79:574\u2013580","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"390_CR46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4132\/jptm.2014.10.13","volume":"49","author":"S Yun","year":"2015","unstructured":"Yun S, Koh JM, Lee KS et al (2015) Expression of c-MET in invasive meningioma. J Pathol Transl Med 49:44\u201351","journal-title":"J Pathol Transl Med"},{"key":"390_CR47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/neup.12524","volume":"39","author":"V Barresi","year":"2019","unstructured":"Barresi V, Lionti S, La Rocca L, Caliri S, Caffo M (2019) High p-mTOR expression is associated with recurrence and shorter disease-free survival in atypical meningiomas. Neuropathology 39:22\u201329","journal-title":"Neuropathology"},{"key":"390_CR48","first-page":"7206","volume":"7","author":"T Backer-Gr\u00f8ndahl","year":"2014","unstructured":"Backer-Gr\u00f8ndahl T, Moen BH, Arnli MB, Torseth K, Torp SH (2014) Immunohistochemical characterization of brain-invasive meningiomas. Int J Clin Exp Pathol 7:7206\u20137219","journal-title":"Int J Clin Exp Pathol"},{"key":"390_CR49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11060-018-2912-7","volume":"139","author":"A Biczok","year":"2018","unstructured":"Biczok A, Kraus T, Suchorska B et al (2018) TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas. J Neurooncol 139:671\u2013678","journal-title":"J Neurooncol"},{"key":"390_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2990.2011.01222.x","volume":"38","author":"M Jansen","year":"2012","unstructured":"Jansen M, Mohapatra G, Betensky R, Keohane C, Louis D (2012) Gain of chromosome arm 1q in atypical meningioma correlates with shorter progression-free survival. Neuropathol Appl Neurobiol 38:213\u2013219","journal-title":"Neuropathol Appl Neurobiol"},{"key":"390_CR51","doi-asserted-by":"publisher","first-page":"e1275","DOI":"10.1016\/j.wneu.2018.11.032","volume":"122","author":"H Li","year":"2019","unstructured":"Li H, Zhang YS, Zhang GB et al (2019) Treatment protocol, long-term follow-up, and predictors of mortality in 302 cases of atypical meningioma. World Neurosurg 122:e1275\u2013e1284","journal-title":"World Neurosurg"},{"key":"390_CR52","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1227\/NEU.0b013e3181eb95b7","volume":"67","author":"A Vranic","year":"2010","unstructured":"Vranic A, Popovic M, Cor A, Prestor B, Pizem J (2010) Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: a study of 86 patients. Neurosurgery 67:1124\u20131132","journal-title":"Neurosurgery"},{"key":"390_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4103\/0973-1482.148708","volume":"11","author":"H Yoon","year":"2015","unstructured":"Yoon H, Mehta MP, Perumal K et al (2015) Atypical meningioma: randomized trials are required to resolve contradictory retrospective results regarding the role of adjuvant radiotherapy. J Cancer Res Ther 11:59\u201366","journal-title":"J Cancer Res Ther"},{"key":"390_CR54","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3171\/2017.9.JNS171609","volume":"130","author":"WC Chen","year":"2018","unstructured":"Chen WC, Magill ST, Wu A et al (2018) Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy. J Neurosurg 130:443\u2013450","journal-title":"J Neurosurg"},{"key":"390_CR55","first-page":"67","volume-title":"Surgical pathology of the nervous system and its coverings","author":"PC Burger","year":"1991","unstructured":"Burger PC, Scheithauer BW, Vogel FT (1991) Meningiomas. Surgical pathology of the nervous system and its coverings, 3rd edn. Churchill Livingstone, New York, pp 67\u201391","edition":"3"},{"key":"390_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10014-005-0187-0","volume":"22","author":"S Nakasu","year":"2005","unstructured":"Nakasu S, Fukami T, Jito J, Matsuda M (2005) Microscopic anatomy of the brain-meningioma interface. Brain Tumor Pathol 22:53\u201357","journal-title":"Brain Tumor Pathol"},{"key":"390_CR57","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2990.2006.00761.x","volume":"32","author":"J Schittenhelm","year":"2006","unstructured":"Schittenhelm J, Mittelbronn M, Roser F, wt al, (2006) Patterns of SPARC expression and basement membrane intactness at the tumour-brain border of invasive meningiomas. Neuropathol Appl Neurobiol 32:525\u2013531","journal-title":"Neuropathol Appl Neurobiol"},{"key":"390_CR58","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/neuonc\/nov247","volume":"18","author":"CL Rogers","year":"2016","unstructured":"Rogers CL, Perry A, Pugh S et al (2016) Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro-Oncol 18:565\u2013574","journal-title":"Neuro-Oncol"},{"key":"390_CR59","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/0090-3019(89)90180-8","volume":"32","author":"S Nakasu","year":"1989","unstructured":"Nakasu S, Hirano A, Llena JF, Shimura T, Handa J (1989) Interface between the meningioma and the brain. Surg Neurol 32:206\u2013212","journal-title":"Surg Neurol"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-020-00390-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10014-020-00390-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-020-00390-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T16:21:57Z","timestamp":1674836517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10014-020-00390-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1007\/s10014-020-00390-y","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"6 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}